The R&D Unit Reinforces our Mission, Vision and Strategy
Dr Om Manchanda, Chief utive Officer, Dr lal Pathlabs on research and development in diagnostics and more Please provide a brief […]
Say something
Tags: Business/Finance, cancers, communicable and non-communicable diseases, delhi, Diseases, Disorders, Gujarat, Health/Medical/Pharmaceuticals, healthcare, India, infectious disease, LAL PATHLABS, Microbiology, Middle East, National Reference Lab, New Delhi, north africa, on processing, state-ofart laboratory information management services, Tripura
Super Religare Laboratories to raise $50m more in PE funding
Avigo Capital and Sabre Capital-backed diagnostics firm Super Religare Laboratories (SRL), which recently withdrew its IPO is raising $50 million(~Rs […]
The Needle of Diagnostics: March 2011
EDITORIAL A New Day, A New Way COVER STORY The Needle Of Diagnostics PERSPECTIVE AT DR LAL PATHLABS,SERVICE,QUALITY AND […]
-
-
Flipkart Health+ App Launched
06-04-2022
